Jingjing Zhang

25PUBLICATIONS
47CO-AUTHORS
BiomaterialsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 17, 2026
Albumin binding improves the pharmacokinetics and therapeutic efficacy of a 177Lu-labeled HER2 Fab radioconjugate.

|Jul 16, 2026
Development of a Long-Acting FAPI Dimer Albb-2FAPI for Diagnosis and Therapy of FAP-Positive Tumors.

|Feb 23, 2026
MSA-2 Loaded Three-Dimensional Metal Covalent Organic Framework for Synergistic Radiosensitization and Innate Immune Activation.

Wenyao Zhen, Wang-Kang Han, Tianzhi Zhao

|Dec 09, 2025
Clinical Translation of a Dual Integrin-and GRPR-targeting PET Radiotracer 68 Ga-DOTA-RGD-RM26 in Glioma.

Rongxi Wang, Ziyang Li, Li'ao Wang

|Oct 24, 2025
¹⁸F-AlF-NOTA-octreotide PET/CT in high-grade G3 neuroendocrine tumors and neuroendocrine carcinomas: diagnostic performance and complementarity with ¹⁸F-FDG PET/CT.

Guozhu Hou, Yuanyuan Jiang, Yi Yang

|Jul 22, 2025
Theranostic Potential of [68Ga]Ga/[177Lu]Lu-LNC1013: A Dual-Purpose Ligand for Cancer Imaging and Radionuclide Therapy.

Peipei Wang, Hongzhe Zhang, Liang Zhao

Pageof 5

Frequent Collaborators

13 joint publications

Xiaoyuan Chen

3 joint publications

Tianzhi Zhao

3 joint publications

Rongxi Wang

3 joint publications

Yizhen Pang